Acute pancreatitis linked to bevacizumab: A case report
Introduction: The monoclonal anti-vascular endothelial growth factor antibody bevacizumab is increasingly being used in the treatment of malignant tumors. It is the first molecular-targeted agent used in the treatment of several ovarian cancers. The typical side effects of this drug are hypertension...
Saved in:
| Main Authors: | Arif Hakan Önder, Banu Öztürk, Ali Murat Tatlı, Erkan Kayıkçıoğlu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Publishing House
2018-08-01
|
| Series: | Journal of Oncological Sciences |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S245233641730105X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An extremely rare neoplasm, histiocytic sarcoma: A report of two cases with an aggressive clinical course
by: Erkan Kayikcioglu, et al.
Published: (2017-07-01) -
PERSPECTIVES ON USE OF BEVACIZUMAB IN PATIENTS WITH NEUROENDOCRINE TUMORS. CASE REPORT
by: G. S. Emelianova, et al.
Published: (2017-12-01) -
Bevacizumab-associated glomerular microangiopathy: a case report and literature review
by: Rui Jiang, et al.
Published: (2025-08-01) -
Case report: Bevacizumab-induced cerebrovascular events: a case series report and literature review
by: Ke Chen, et al.
Published: (2025-02-01) -
Case report: A case of acute pancreatitis with myocarditis and thyrotoxicosis
by: Qiuyu Fu, et al.
Published: (2025-06-01)